Ebola Viral Infections-Pipeline Insights, 2014

1
Ebola Viral Infections-Pipeline Insights,
2014
One-Stop Shop for Business Information
2
Summary
'Ebola Viral Infections-Pipeline Insights, 2014',
report provides comprehensive insights about
pipeline drugs across this indication. A key
objective of the report is to establish the
understanding for all the pipeline drugs that
fall under Ebola Viral Infections. This report
provides information on the therapeutic
development based on the Ebola Viral Infections
dealing with all the pipeline drugs, comparative
analysis at various stages covering Filed, Phase
III, Phase II, Phase I, IND filed, Preclinical,
Discovery and unknown stages, therapeutics
assessment by monotherapy and combination
products and molecule type drug information. The
report also covers the companies information
involved in the therapeutic development of the
products. It also has highlighted the
discontinued and dormant products.
3
Secondary sources information and data has been
collected from various printable and
non-printable sources like search engines, News
websites, Government Websites, Trade Journals,
White papers, Magazines, Trade associations,
Books, Industry Portals, Industry Associations
and access to available databases.Scope The
report provides a snapshot of the global
therapeutic landscape of Ebola Viral Infections
The report provides pipeline products under drug
profile section which includes product
description, MOA, licensors collaborators,
development partner and chemical information
4
Coverage of the Ebola Viral Infections pipeline
on the basis of target, MOA, route of
administration, technology involved and molecule
type The report reviews key players involved in
the therapeutics development for Ebola Viral
Infections and also provide company profiling
The report also gives the information of dormant
and discontinued pipeline projects  Pipeline
products coverage based on various stages of
development ranging from preregistration till
discovery and undisclosed stages  Provides
pipeline assessment by monotherapy and
combination therapy products, stage of
development and molecule type
5
- The report reviews key players involved in the
therapeutics development for Ebola Viral
Infections and enlists all their major and minor
projects- The report summarizes all the dormant
and discontinued pipeline projects - A review of
the Ebola Viral Infections products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources- Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages- A detailed
assessment of monotherapy and combination therapy
pipeline projects- Coverage of the Ebola Viral
Infections pipeline on the basis of target, MoA,
route of administration and molecule type-
Latest news and deals relating related to
pipeline products
6
Reasons to buy Complete Pipeline intelligence
and complete understanding over therapeutics
development for Ebola Viral Infections Identify
the relationship between the drugs and use it for
target finding, drug repurposing, and precision
medicine. Devise corrective measures for
pipeline projects by understanding Ebola Viral
Infections pipeline depth and focus of Indication
therapeutics  Developing strategic initiatives
to support your drug development activities.
Optimize your portfolio and keep you in touch
with the rapidly changing pharmaceutical markets,
and make the best decisions for your business.
7
Develop and design in licensing and out
licensing strategies by identifying prospective
partners with the most attractive projects to
enhance and expand business potential and
scope  Provides strategically significant
competitor information, analysis, and insights to
formulate effective RD development strategies 
Modify the therapeutic portfolio by identifying
discontinued projects and understanding the
factors that drove them from pipeline Gaining a
Full Picture of the Competitive Landscape for
Evidence based Decisions
8
Table Of Content

• Ebola Viral Infections Overview
• Ebola Viral Infections Pipeline Therapeutics
• Ebola Viral Infections Therapeutics under
  Development by Companies
• Ebola Viral Infections Late Stage Products
  (Filed and Phase III)
• Comparative Analysis
• Ebola Viral Infections Mid Clinical Stage
  Products (Phase II)
• Comparative Analysis
• Ebola Viral Infections Early Clinical Stage
  Products (Phase I and IND Filed)
• Comparative Analysis
• Ebola Viral Infections Discovery and
  Pre-Clinical Stage Products

9

• To know more
• Ebola Viral Infections-Pipeline Insights, 2014

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com